DNA X announces private placement of 1,346,531 Series B preferred shares for USD 8.1 million

DNA X

DNA X

SONM

0.00

  • DNA X entered a private placement to sell 1,346,531 shares of non-voting Series B Convertible Preferred Stock at USD 6 per share.
  • Transaction size USD 8.1 million, comprised of USD 5 million cash, cancellation of USD 3.1 million on a May 2026 convertible promissory note.
  • Buyer DNA Holdings Venture, an affiliate of director Scott Walker, holds more than 5% of the outstanding stock.
  • Series B converts automatically to common stock after shareholder approval, at an initial conversion price equal to stated value.
  • Unregistered offering under Securities Act exemptions; proceeds earmarked for working capital, general corporate purposes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DNA X Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-031675), on July 02, 2026, and is solely responsible for the information contained therein.